Visionary Venture Fund is a Aliso Viejo, California based venture capital firm. They focus their investments on emerging ophthalmology companies with medical devices, medical technologies and pharmaceuticals.
They look for proven management teams with ideas to meet unmet needs in ophthalmology. And they target their investments in the $500,000 to $5 million in financing rounds from Series A to commercialization. In their investments, Visionary Venture Fund wants to be a lead investor and a partner of choice.
Investments
In May, 2017 Visionary Venture Fund announced they closed their first round of financing at $30 million. They sought to use the fund to invest in twelve ophthalmology companies, including micro-interventional cataract device treatment devloper IanTech.
Their investments include CorneaGen, Equinox, IanTech, Zepto, Orasis, Rxsight, Surface Pharmaceuticals, Tear Film Innovations and Tearclear.
Timeline
People
Bill Carpou
Investment Advisor
Dr. Bob Avery
Investment Advisor
Dr. Dick Lindstrom
Investment Advisor
Dr. Ehsan Sadri
Investment Advisor
Dr. Toby Tyson
Investment Advisor
Garrett Hamontree
Principal
Jeffry Weinhuff
Investment Advisor & Managing Partner
Natalie Paz
Fund Administrator
